These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3542236)

  • 1. Antigen-specific augmentation of delayed-type hypersensitivity by immune serum factor in mice: augmentation of anti-tumor cytostatic activity.
    Nakamura S; Himeno K; Yamada A; Mitani M; Nomoto K
    Cell Immunol; 1986 Dec; 103(2):311-25. PubMed ID: 3542236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice.
    Mitani M; Mori K; Himeno K; Nomoto K
    J Immunol; 1989 Mar; 142(6):2148-54. PubMed ID: 2493508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific augmentation factor involved in murine delayed-type footpad reaction. IV. Effect of delayed-type hypersensitivity augmentation factor on in vitro induction of DTH.
    Nakamura S; Himeno K; Yamada A; Kawamura I; Nomoto K
    Cell Immunol; 1987 Mar; 105(1):54-64. PubMed ID: 2434252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific augmentation factor involved in murine delayed-type footpad reaction. II. Augmentation of delayed-type footpad reaction and acquired resistance to Listeria monocytogenes by transfer of Listeria-immune serum.
    Himeno K; Yamada A; Kawakita T; Nakamura S; Mitsuyama M; Nomoto K
    Med Microbiol Immunol; 1987; 176(5):229-39. PubMed ID: 2443824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific augmentation of delayed-type hypersensitivity by a humoral factor in the culture supernatant of immune spleen cells.
    Yamada A; Himeno K; Kumazawa Y; Nomoto K
    Cell Immunol; 1984 Mar; 84(1):206-9. PubMed ID: 6199121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of delayed hypersensitivity and cytostatic macrophages in the rejection of an allo-transplantable murine tumor.
    Tomita Y; Himeno K; Fujiki M; Nomoto K; Hirohata T
    Oncology; 1981; 38(5):301-6. PubMed ID: 6973733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific augmentation factor involved in murine delayed-type footpad reaction. III. Genetic restriction of delayed hypersensitivity augmentation factor (DAF).
    Yamada A; Himeno K; Nakamura S; Nomoto K
    Immunobiology; 1987 Dec; 176(1-2):24-34. PubMed ID: 3129361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
    Mitani M; Matsumoto T; Mori K; Miake S; Himeno K; Nomoto K
    J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice.
    Koga T; Mitsuyama M; Handa T; Yayama T; Muramori K; Nomoto K
    Immunology; 1987 Oct; 62(2):241-8. PubMed ID: 2445666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in the functional maturation of T cells against Listeria monocytogenes in lymph nodes and spleen.
    Serushago BA; Mitsuyama M; Handa T; Muramori K; Koga T; Nomoto K
    Immunology; 1992 Feb; 75(2):238-44. PubMed ID: 1551686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific augmentation factor involved in murine delayed-type footpad reaction. I. Nature of augmentation factor.
    Yamada A; Himeno K; Miyata H; Kumazawa Y; Nomoto K
    Cell Immunol; 1984 Oct; 88(1):184-92. PubMed ID: 6478513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.
    De Weger RA; Pels E; Den Otter W
    Immunology; 1982 Nov; 47(3):541-50. PubMed ID: 6215342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pertussis toxin (PT) on T-cell populations sensitized for delayed-type hypersensitivity in mice.
    Tamura SI; Nakanishi Y; Kojima A; Otokawa M; Uchida N; Sato H; Sato Y
    Cell Immunol; 1984 May; 85(2):351-63. PubMed ID: 6609000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific augmentation of murine immediate hypersensitivity-like footpad reaction by a T-cell factor in the culture supernatant of immune spleen cells.
    Yamada A; Himeno K; Kumazawa Y; Nomoto K
    Cell Immunol; 1985 May; 92(2):350-8. PubMed ID: 2581706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties.
    Nagarkatti M; Clary SR; Nagarkatti PS
    J Immunol; 1990 Jun; 144(12):4898-905. PubMed ID: 1972170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective induction of delayed hypersensitivity T-effector and T-suppressor lymphocytes in vitro by haptenized bone marrow-derived macrophages.
    Knop J; Malorny U; Macher E
    Cell Immunol; 1984 Oct; 88(2):411-20. PubMed ID: 6237731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of T cells involved in the expression of delayed hypersensitivity and tumor rejection immunity to 13762A rat mammary adenocarcinoma.
    Kreider JW; Howell LE; Bartlett GL
    Cell Immunol; 1985 Jun; 93(1):26-37. PubMed ID: 3922632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism.
    Hammond ME; Selvaggio SS; Dvorak HF
    J Immunol; 1975 Oct; 115(4):914-21. PubMed ID: 1100724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.